Abbott declared a quarterly common dividend of $0.63 per share, continuing its long-standing track record of shareholder returns. This marks the company’s 411th consecutive quarterly dividend payment since 1924.

The board of directors announced the payout on September 17, 2026. The cash dividend is payable on November 16, 2026, to shareholders of record at the close of business on October 15, 2026.

Dividend History

Abbott has increased its dividend payout for 54 consecutive years. The company is a member of the S&P 500 Dividend Aristocrats Index, which tracks firms that have raised dividends annually for at least 25 consecutive years.

What the Numbers Show

The declaration underscores Abbott’s commitment to consistent capital return. With 54 consecutive years of increases, the firm maintains a high bar for financial discipline required to remain in the Dividend Aristocrats Index, signaling stability in its cash flow generation despite broader market volatility.

Abbott has agreed to pay over $384 million to the U.S. Justice Department to settle allegations related to contaminated infant formula. The settlement resolves legal claims stemming from safety concerns regarding its baby food products.

Settlement Details

The agreement addresses allegations that Abbott failed to properly test and monitor its infant formula for contaminants. The company will pay the specified amount to resolve these matters without admitting wrongdoing.

What the Numbers Show

The $384 million settlement represents a material cash outflow for Abbott. This figure reflects the cost of resolving regulatory and legal risks associated with product safety failures, impacting near-term liquidity and net income.

• Abbott agrees to pay over $384 million in settlement.
• The payment resolves allegations of contaminated infant formula.
• The deal was announced by the U.S. Justice Department.